REPEAT New Study Showed VYTORIN
Selected Abstract
REPEAT/New Study Showed VYTORIN(R) (ezetimibe/simvastatin) Significantly More Effective than Crestor(R) (rosuvastatin) at Lowering LDL ''Bad'' Cholesterol At All Doses Compared.
ROME -- Greater LDL Cholesterol Reduction with VYTORIN Compared to Crestor Resulted in Greater LDL Cholesterol Goal Attainment Results from a new clinical study which included 2,855 patients with high cholesterol showed that VYTORIN(R) (ezetimibe/simvastatin) was significantly more effective than ... June 19, 2006; Business Wire
Read the full article with a free-trial membership at HighBeam Research
Related Articles 1.
REPEAT/New Study Showed VYTORIN(R) (ezetimibe/simvastatin) Superior to Lipitor in Reducing LDL ''Bad'' Cholesterol in Patients with Type II Diabetes at the Recommended Usual Starting Doses.
2.
REPEAT/New Study Showed VYTORIN(R) (ezetimibe/simvastatin) Significantly More Effective than Crestor(R) (rosuvastatin) at Lowering LDL ''Bad'' Cholesterol At All Doses Compared.
|
